Answer
Severe skin reactions listed for Keytruda (pembrolizumab) include Grade 3 or 4 skin reactions, Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN).
Sources for this answer
- KEYTRUDA 25 mg/mL concentrate for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.2 Posology and method of administration · Version 64Document updated
Sources checked